BG61025B1 - Използване на хинони при лечение на рак или спин - Google Patents

Използване на хинони при лечение на рак или спин Download PDF

Info

Publication number
BG61025B1
BG61025B1 BG98041A BG9804193A BG61025B1 BG 61025 B1 BG61025 B1 BG 61025B1 BG 98041 A BG98041 A BG 98041A BG 9804193 A BG9804193 A BG 9804193A BG 61025 B1 BG61025 B1 BG 61025B1
Authority
BG
Bulgaria
Prior art keywords
composition according
acid
mol
quinone
composition
Prior art date
Application number
BG98041A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG98041A (bg
Inventor
Washington O Ayuko
Original Assignee
Radopath Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Radopath Ltd filed Critical Radopath Ltd
Publication of BG98041A publication Critical patent/BG98041A/bg
Publication of BG61025B1 publication Critical patent/BG61025B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B1/00—Dyes with anthracene nucleus not condensed with any other ring
    • C09B1/02—Hydroxy-anthraquinones; Ethers or esters thereof
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B67/00—Influencing the physical, e.g. the dyeing or printing properties of dyestuffs without chemical reactions, e.g. by treating with solvents grinding or grinding assistants, coating of pigments or dyes; Process features in the making of dyestuff preparations; Dyestuff preparations of a special physical nature, e.g. tablets, films
    • C09B67/0033—Blends of pigments; Mixtured crystals; Solid solutions
    • C09B67/0034—Mixtures of two or more pigments or dyes of the same type
    • C09B67/0038—Mixtures of anthraquinones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BG98041A 1991-02-13 1993-08-13 Използване на хинони при лечение на рак или спин BG61025B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919103075A GB9103075D0 (en) 1991-02-13 1991-02-13 Trinitrobenzene derivatives and their therapeutic use
PCT/GB1992/000262 WO1992014454A1 (fr) 1991-02-13 1992-02-13 Utilisation de quinones dans le traitement du cancer ou du sida

Publications (2)

Publication Number Publication Date
BG98041A BG98041A (bg) 1994-05-27
BG61025B1 true BG61025B1 (bg) 1996-09-30

Family

ID=10689992

Family Applications (1)

Application Number Title Priority Date Filing Date
BG98041A BG61025B1 (bg) 1991-02-13 1993-08-13 Използване на хинони при лечение на рак или спин

Country Status (30)

Country Link
EP (1) EP0499467A3 (fr)
JP (1) JPH06505231A (fr)
CN (1) CN1064407A (fr)
AP (1) AP549A (fr)
AU (2) AU1233992A (fr)
BG (1) BG61025B1 (fr)
BR (1) BR9205642A (fr)
CA (1) CA2104009A1 (fr)
CZ (1) CZ166893A3 (fr)
DZ (1) DZ1559A1 (fr)
FI (1) FI933595A0 (fr)
GB (2) GB9103075D0 (fr)
GT (1) GT199200009A (fr)
HU (1) HUT65634A (fr)
IE (1) IE920464A1 (fr)
IL (1) IL100906A (fr)
IN (1) IN178929B (fr)
IS (1) IS3814A (fr)
JO (1) JO1719B1 (fr)
LT (1) LT3197B (fr)
MA (1) MA22443A1 (fr)
MX (1) MX9200622A (fr)
MY (1) MY131098A (fr)
NO (1) NO932681L (fr)
NZ (2) NZ240487A (fr)
OA (2) OA09535A (fr)
SK (1) SK87993A3 (fr)
TN (1) TNSN92015A1 (fr)
WO (1) WO1992014454A1 (fr)
ZA (1) ZA921037B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9103075D0 (en) 1991-02-13 1991-03-27 Washington Odur Ayuko Trinitrobenzene derivatives and their therapeutic use
DZ1781A1 (fr) * 1993-05-21 2002-02-17 Radopah Ltd Agents d'arylation.
DE69519722D1 (de) * 1994-03-17 2001-02-01 Radopath Pharmaceuticals Inter Wirkstof gegen viren und krebs
ATE188870T1 (de) * 1994-10-04 2000-02-15 Lohmann Rudolf Lomapharm Lösungen von anthrachinonen zur parenteralen applikation
US7482029B2 (en) 2005-04-01 2009-01-27 Bionovo, Inc. Composition for treatment of menopause
US7537774B2 (en) * 2005-12-23 2009-05-26 Orion Therapeautics, Llc Therapeutic formulation
WO2009021196A1 (fr) 2007-08-08 2009-02-12 Bionovo, Inc. Extraits de ligustrum lucidum et leurs utilisations
WO2009033099A1 (fr) 2007-09-07 2009-03-12 Bionovo, Inc. Extraits oestrogéniques de astragalus membranaceus fisch.bge.var.mongolicus bge. de la famille leguminosae et leurs utilisations
JP2010538090A (ja) 2007-09-07 2010-12-09 バイオノボ・インコーポレーテッド ユリ科ファミリーのクサスギカズラのエストロゲン性抽出物およびその使用
WO2009033075A1 (fr) 2007-09-07 2009-03-12 Bionovo. Inc. Extraits oestrogéniques de scuttelaria barbata d. don de la famille labiatae et leurs utilisations
EP2060562A1 (fr) * 2007-11-16 2009-05-20 Laboratoire Medidom S.A. Dérivés de sulfonate de dioxoanthracène
EP2219659A4 (fr) 2007-11-19 2010-11-17 Bionovo Inc Procédés de détection et de traitement de cancers utilisant un extrait de scuttelaria barbata
CA2706330A1 (fr) 2007-11-19 2009-06-04 Bionovo, Inc. Procede de fabrication d'extrait purifie de la scutellaria barbata d.don
WO2009148620A2 (fr) * 2008-06-06 2009-12-10 Bionovo, Inc. Anthraquinones et analogues provenant de rheum palmatum pour le traitement d'états à médiation par le récepteur bêta de l'œstrogène
US9884815B2 (en) * 2011-10-14 2018-02-06 Emory University PGAM1 inhibitors and methods related thereto
CZ304335B6 (cs) * 2012-02-22 2014-03-12 Mikrobiologický ústav AV ČR, v. v. i. Submerzní kmeny Quambalaria sp. CCM 8372 a CCM 8373, směs naftochinonových barviv jimi produkovaná, způsob jejich produkce a použití
US20210309860A1 (en) * 2018-07-17 2021-10-07 Pili Anthraquinonic derivatives and their use as colouring agents

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7708452L (sv) * 1977-07-22 1979-01-23 Allied Chem Komposition innehallande en antrakinonforening
JPS6054286B2 (ja) * 1979-09-18 1985-11-29 江澤 林 免疫増強剤
JPS6043210A (ja) * 1983-08-18 1985-03-07 Tdk Corp 磁気ヘツド及びその製造方法
DE3431236A1 (de) * 1984-08-24 1986-02-27 Carnivora-Deutschland GmbH, 7109 Jagsthausen Verwendung von 1,4-naphthochinon-derivaten in niedrigen konzentrationen zur immunstimulation
DE3601065A1 (de) * 1986-01-16 1987-07-23 Behringwerke Ag Chinon-derivate als antitumormittel
DE3879688T2 (de) * 1987-12-10 1993-07-01 Tsumura & Co Anti-retrovirales arzneimittel.
DE68914930T2 (de) * 1988-08-16 1994-08-18 Wellcome Found Naphtochinone zur Behandlung und Prophylaxe von Pneumocystis carinii-Infektionen.
GB9103075D0 (en) 1991-02-13 1991-03-27 Washington Odur Ayuko Trinitrobenzene derivatives and their therapeutic use
WO1991015200A2 (fr) * 1990-04-03 1991-10-17 Radopath Limited Utilisation trinitrobenzenes ou d'acide carminique pour le traitement du cancer ou de maladies virales
DE4013023A1 (de) * 1990-04-24 1991-11-07 Lohmann Rudolf Lomapharm Verwendung von anthrachinonderivaten zur prophylaxe und therapie von viruserkrankungen

Also Published As

Publication number Publication date
MX9200622A (es) 1992-11-01
FI933595A (fi) 1993-08-13
HU9302347D0 (en) 1993-10-28
WO1992014454A1 (fr) 1992-09-03
GB9203084D0 (en) 1992-03-25
EP0499467A3 (en) 1992-12-16
JO1719B1 (en) 1992-12-15
CN1064407A (zh) 1992-09-16
NZ241593A (en) 1995-05-26
NO932681L (no) 1993-10-07
IN178929B (fr) 1997-07-19
GB2254554B (en) 1995-09-20
OA09535A (en) 1992-11-15
GT199200009A (es) 1993-08-06
IE920464A1 (en) 1992-08-12
NZ240487A (en) 1994-03-25
CA2104009A1 (fr) 1992-08-14
BG98041A (bg) 1994-05-27
AU5590696A (en) 1996-08-08
HUT65634A (en) 1994-07-28
GB2254554A (en) 1992-10-14
AU1233992A (en) 1992-09-15
JPH06505231A (ja) 1994-06-16
FI933595A0 (fi) 1993-08-13
IL100906A (en) 1996-09-12
TNSN92015A1 (fr) 1993-06-08
AP9200356A0 (en) 1992-04-30
IS3814A (is) 1992-08-14
IL100906A0 (en) 1992-11-15
DZ1559A1 (fr) 2002-02-17
BR9205642A (pt) 1994-06-21
ZA921037B (en) 1992-11-25
AP549A (en) 1996-11-01
LTIP329A (en) 1994-08-25
GB9103075D0 (en) 1991-03-27
MY131098A (en) 2007-07-31
SK87993A3 (en) 1993-12-08
OA09810A (en) 1994-04-15
CZ166893A3 (en) 1994-03-16
MA22443A1 (fr) 1992-10-01
EP0499467A2 (fr) 1992-08-19
NO932681D0 (no) 1993-07-26
LT3197B (en) 1995-03-27

Similar Documents

Publication Publication Date Title
BG61025B1 (bg) Използване на хинони при лечение на рак или спин
EP0201275B1 (fr) Compositions pharmaceutiques pour le traitement des métastases de tumeurs cancéreuses
US20040101573A1 (en) Injectable composition for cancer treatment
NL8501995A (nl) Werkwijze voor het remmen van acuut stralingssyndroom en het optreden van septiceem en daarvoor te gebruiken preparaat.
AU662883B2 (en) Use of trinitrobenzenes or carminic acid in the treatment of cancer or viral diseases
OA12862A (en) Compositions for therapeutic use comprising a vitamin, a metal salt and insulin or a growth hormone.
US20080206736A1 (en) Flavin n-oxides: new anti-cancer agents and pathogen eradication agents
Splinter et al. Phase I study of alpha-difluoromethylornithine and methyl-GAG
US7439234B2 (en) Method for treating cancer patients undergoing chemotherapy
KR100514009B1 (ko) 1,2,4-벤조트리아진옥사이드제제
US6306901B1 (en) Agent for prophylaxis and therapy of diseases
JP2004315470A (ja) ヨウ化ナトリウム含有製剤
EP1210944A1 (fr) Solution de remplacement du plasma sanguin
CN111803482B (zh) 鹿茸单体在制备抑制乳腺肿瘤骨转移的药物中的应用及药物
EP1203585B1 (fr) Agent anti-ischemique
Clifford et al. Dimethyl myleran therapy combined with abdominal aortic occlusion
KR20070030246A (ko) 자궁 종양 치료용 약제의 제조를 위한7-티-부톡시이미노메틸캄토테신의 용도
HRP920891A2 (en) Quinone preparation
RU2026679C1 (ru) Способ противоопухолевой терапии при первичном раке печени
KR20020026743A (ko) 비소화합물 및 글루타치온 고갈 유도 화합물을 함유하는항암조성물
HU179753B (en) Process for producting synergetic pharmaceutical compositions of citostatic activity
US20020123480A1 (en) Methods and compositions utilizing 2&#39;-5&#39; oligoadenylates in the treatment of disorders of cell proliferation